Study #2022-0229
Comparing the Effectiveness of Surgery versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (SORT Trial)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The development of stereotactic body radiation therapy (SBRT) for the treatment of stage I non-small cell lung cancer (NSCLC) has inspired a close partnership between thoracic surgery and radiation oncology. In this study, patients with stage I NSCLC will be screened prior to treatment and will be consented after their treatment plan has been determined. Prospectively collected patient-reported outcomes (PROs) will be collected for 3 years, as will outcomes data.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Non Small Cell Lung Cancer;Non-small Cell Lung Cancer
Study phase:
Physician name:
Ara Vaporciyan
Department:
Thoracic & Cardiovascular Surgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.